Pioglitazone repurposing via in-situ gelling system: An effective topical strategy for wound management
Authors:
- Dalia H. AbdelkaderDalia H. Abdelkader
- Samar M. ElshaerSESamar M. Elshaer
- Eman A. ElkordyEEEman A. Elkordy
- Naglaa I. SarhanNSNaglaa I. Sarhan
- Ebtessam A. EssaEEEbtessam A. Essa
- 18 February 2025
- journal article
- Published by Elsevier in Journal of Drug Delivery Science and Technology
- Vol. 106
Abstract
No abstract availableThis publication has 54 references indexed in Scilit:
- Thermal degradation of Affinisol HPMC: Optimum Processing Temperatures for Hot Melt Extrusion and 3D PrintingPharmaceutical Research, 2023
- Development of a novel in situ gelling skin dressing: Delivering high levels of dissolved oxygen at pH 5.5.Health Science Reports, 2018
- Chronic Wound Healing: A Review of Current Management and TreatmentsAdvances in Therapy, 2017
- Macrophage PPARγ and impaired wound healing in type 2 diabetesThe Journal of Pathology, 2015
- Investigation of human body skin temperatures as a bio-signal to indicate overall thermal sensationsBuilding and Environment, 2012
- Pioglitazone inhibits TGFβ induced keratocyte transformation to myofibroblast and extracellular matrix productionMolecular Biology Reports, 2010
- The use of physical hydrogels of chitosan for skin regeneration following third-degree burnsBiomaterials, 2007
- A Review of Poloxamer 407 Pharmaceutical and Pharmacological CharacteristicsPharmaceutical Research, 2006
- The Many Faces of PPARγCell, 2005
- Temperature-dependent rheological behavior of Pluronic F-127 aqueous solutionsInternational Journal of Pharmaceutics, 1987